In rural Hastings, Neb., ophthalmologist John Welch said the vast majority of the $9.5 million that Medicare paid him went straight from his practice to drug companies, for expensive medications used to treat patients with macular degeneration.
"I'm concerned that people in the community will get the wrong idea of how these billings reflect doctors' income," said Welch, who ranked No. 8 in Medicare payments. "Instead of blaming us, they need to have a serious discussion with the drug companies about lowering the cost of these drugs. If they want us to stop taking care of patients, then tell us that - but don't blame us for costs."